Analysis of decision making at a multidisciplinary head and neck tumor board incorporating evidence-based National Cancer Comprehensive Network (NCCN) guidelines-Reference-Cited by-同舟云学术

Analysis of decision making at a multidisciplinary head and neck tumor board incorporating evidence-based National Cancer Comprehensive Network (NCCN) guidelines

Published:2016-07 Issue:4 Volume:6 Page:248-254
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Shah Bhartesh A.,Qureshi Muhammad M.,Jalisi Scharukh,Grillone Gregory,Salama Andrew,Cooley Timothy,Zaner Ken,Sakai Osamu,Truong Minh Tam

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference14 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Multidisciplinary teams in cancer care: Are they effective in the UK?;Fleissig;Lancet Oncol,2006

3. Quality of care management decisions by multidisciplinary cancer teams: A systematic review;Lamb;Ann Surg Oncol,2011

4. Multidisciplinary clinical approach to the management of head and neck cancer;Bradley;Eur Arch Otorhinolaryngol,2012

5. OncologyVersion v. 1;NCCN Practice Guidelines,2009

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-volume facilities are significantly more likely to use guideline-adherent systemic immunotherapy for metastatic Merkel cell carcinoma: implications for cancer care regionalization;Archives of Dermatological Research;2024-02-13

2. A proposed framework for the implementation of head and neck cancer treatment at a new cancer center from a radiation oncology perspective;Asia-Pacific Journal of Clinical Oncology;2023-04-26

3. Levels of Evidence for Radiation Therapy Recommendations in the National Comprehensive Cancer Network (NCCN) Clinical Guidelines;Advances in Radiation Oncology;2022-01

4. Association of Treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma;JAMA Dermatology;2021-05-01

5. A comparison of cisplatin cumulative dose and cisplatin schedule in patients treated with concurrent chemo-radiotherapy in nasopharyngeal carcinoma;Brazilian Journal of Otorhinolaryngology;2020-11